Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
You have these already downloaded
We have sent you a copy of the report to your email again.
The future of the pharmaceutical industry is gearing towards utilizing technologies in an innovative way to steer drug delivery.
Artificial intelligence (AI) is touted to reshape the pharmaceutical industry, right from the earliest stage—drug research—to the production stage, and ultimately, to the rollout of life-altering treatments. The three AI trends transforming the pharma sector this year are growth in development of drugs and devices from in vivo to in silico, the use of AI to personalize patient journey, and the focus on guarding the privacy of patients through synthetic data generation with AI algorithms.
There’s been a gradual shift from traditional and time-consuming in-vivo methods to in-silico drug testing driven by AI to facilitate virtual testing of new drug molecules and medical devices.
This has fast-tracked the development process. Generative AI (GenAI) has made faster go-to-market strategies possible for new drugs. AI-enabled digital twins of organs are giving a boost to new therapies.
Smart AI usage and application will redefine pharma, paving the path for an exciting future, be it advancing drug discovery, personalizing patient care, or augmenting operations. AI is being used to increase innovation and efficiency for better outcomes as well as support pharma professionals amid rising treatment and therapy demands and challenges ahead.
In an article in Pharmafocus, Vikas Jain, VP and Business Head of Life Sciences, Tata Consultancy Services, elaborates on the three key trends being shaped by AI in pharma and how they will transform the industry.
Pharmafocus is a magazine that reports on the latest trends in the pharma industry, drug development and clinical trials, manufacturing, logistics, market access, and patient care.
Read the complete article here: https://www.pharmafocus.com/articles/the-future-of-pharma-how-ai-will-reshape-drug-development-and-p
Integrated ecosystems are key to better patient outcomes.
Talk to our experts